Saturday, November 8, 2008

Merck’s Heart Remains Steadfast in Hunt for Cardiovascular Drugs

The drugmaker affirmed its commitment to research on drugs for heart disease, in marked contrast to Pfizer's recent decision to leave the field.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)